ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Sanofi CDR

Sanofi CDR (SNY)

19,50
-0,09
(-0,46%)
Geschlossen 09 Juli 10:12PM

Sanofi CDR (SNY) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
19,50
( -0,46% )
Gebot
19,40
Fragen
19,54
Volumen
100
Durchschnittliches Volumen (3 Mio.)
$ 2.491.718
Finanzvolumen
-
19,54 Tagesbereich 19,54
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Unternehmenswert
105,801B
Handelsende
19,59
Handelsbeginn
19,54
Letzte Trade
100
@
19.54
Letzter Handelszeitpunkt
VWAP
-
Erlöse (LTM)
47,35B
Nettogewinn (LTM)
7,56B
Ausgegebene Aktien
1.200.220.109
Streubesitz (%)
90,30%
Institutioneller Besitz (%)
44,40%
Dividendenrendite (LTM)
(5,35%)
Kurs-Gewinn-Verhältnis
19,12
Kurs-Umsatz-Verhältnis (KUV)
1,92
Gewinn pro Aktie (EPS)
6,2
Beta
0,28

Über Sanofi CDR

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respi... Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine’s AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV’574, for treatment of ulcerative colitis and Crohn’s disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France. Mehr anzeigen

Sektor
-
Branche
-
Website
Hauptsitz
Paris, France
Gegründet
1994
Sanofi CDR is listed in the sector of the Toronto Börse with ticker SNY. The last closing price for Sanofi CDR was $19,59. Over the last year, Sanofi CDR shares have traded in a share price range of $ 0,00 to $ 0,00.

Sanofi CDR currently has 1.200.220.109 shares in issue. The market capitalisation of Sanofi CDR is $23,40 billion. Sanofi CDR has a price to earnings ratio (PE ratio) of 19.12.

SNY Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

SNY - Frequently Asked Questions (FAQ)

What is the current Sanofi CDR share price?
The current share price of Sanofi CDR is $ 19,50
How many Sanofi CDR shares are in issue?
Sanofi CDR has 1.200.220.109 shares in issue
What is the market cap of Sanofi CDR?
The market capitalisation of Sanofi CDR is CAD 23,4B
What is the 1 year trading range for Sanofi CDR share price?
Sanofi CDR has traded in the range of $ 0,00 to $ 0,00 during the past year
What is the PE ratio of Sanofi CDR?
The price to earnings ratio of Sanofi CDR is 19,12
What is the cash to sales ratio of Sanofi CDR?
The cash to sales ratio of Sanofi CDR is 1,92
What is the registered address of Sanofi CDR?
The registered address for Sanofi CDR is 46, avenue de la Grande ArmEe, Paris, Ile-de-France, 75017
What is the Sanofi CDR website address?
The website address for Sanofi CDR is www.sanofi.com

SNY Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen